Szyman Catherine M.
SEC CIK 1438538 · EDGAR
BoughtSold
Most active insiders at EW, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOBO DONALD E JR | CVP, Strategy, Corp Development | — | $11.15M |
| 2 | Zovighian Bernard J | CEO, Dir | — | $7.00M |
| 3 | Ullem Scott B. | CFO, CVP | — | $3.87M |
| 4 | Chopra Daveen | CVP, TMTT, Surgical, IHFM | — | $3.19M |
| 5 | Markowitz Wayne | CVP, JAPAC | — | $1.04M |
| 6 | Lippis Daniel J. | CVP, TAVR | — | $871.6K |
| 7 | Bruls Annette | CVP, EMEACLA | — | $237.9K |
| 8 | STONE HEISZ LESLIE | Dir | — | $218.1K |
| 9 | Dahl Andrew M. | SVP, Corp. Ctrl | — | $98.4K |
| 10 | Davis Leslie C. | Dir | — | — |
Szyman Catherine M. made no open-market trades at EW in the last 12 months.
Transactions 56
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-03 | 2024-09-03 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +10.9K | 86.8K | +14% | $0 | |
| 2024-09-03 | 2024-09-03 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $69.96 | -5,530 | 81.3K | -6% | -$386.9K | |
| 2024-07-08 | 2024-07-07 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $92.32 | -258 | 75.9K | -0.3% | -$23.8K | |
| 2024-05-13 | 2024-05-11 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $86.72 | -827 | 76.2K | -1% | -$71.7K | |
| 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $85.09 | -609 | 77.0K | -0.8% | -$51.8K | |
| 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +32.0K | 77.6K | +70% | $0 | |
| DM | 2024-05-06 | 2024-05-03+ | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $85.23 | -3,921 | 43.2K | -8% | -$334.2K |
| D | 2024-05-06 | 2024-05-04 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $0.00 | +5,796 | 49.0K | +13% | $0 |
| 2024-02-23 | 2024-02-22 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +8,560 | 43.4K | +25% | $0 | |
| DM | 2024-02-15 | 2024-02-13+ | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $85.98 | -47.0K | 34.8K | -57% | -$4.04M |
| DM | 2024-02-15 | 2024-02-13+ | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +47.0K | 61.8K | +317% | +$1.73M |
| D | 2023-10-10 | 2023-10-10 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 39.8K | +14% | +$183.8K |
| D | 2023-10-10 | 2023-10-10 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $72.68 | -5,000 | 34.8K | -13% | -$363.4K |
| D | 2023-09-08 | 2023-09-08 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $76.00 | -5,000 | 34.8K | -13% | -$380.0K |
| D | 2023-09-08 | 2023-09-08 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 39.8K | +14% | +$183.8K |
| D | 2023-08-09 | 2023-08-09 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $78.64 | -5,000 | 34.8K | -13% | -$393.2K |
| D | 2023-08-09 | 2023-08-09 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 39.8K | +14% | +$183.8K |
| D | 2023-07-10 | 2023-07-07 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $90.46 | -252 | 34.8K | -0.7% | -$22.8K |
| D | 2023-07-10 | 2023-07-10 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 39.8K | +14% | +$183.8K |
| D | 2023-07-10 | 2023-07-10 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $90.52 | -5,000 | 34.8K | -13% | -$452.6K |
| D | 2023-06-13 | 2023-06-13 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $85.81 | -5,000 | 35.1K | -12% | -$429.1K |
| D | 2023-06-13 | 2023-06-13 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +5,000 | 40.1K | +14% | +$183.8K |
| 2023-05-31 | 2023-05-31 | OM | Outset Medical, Inc. | Szyman Catherine M. | Dir | A - Grant | $0.00 | +7,681 | 24.6K | +45% | $0 | |
| D | 2023-05-15 | 2023-05-11 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +6,525 | 35.1K | +23% | $0 |
| DM | 2023-05-09 | 2023-05-07+ | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $88.74 | -3,530 | 28.5K | -11% | -$313.3K |
| DM | 2023-05-09 | 2023-05-07+ | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $33.14 | +80.3K | 104.1K | +337% | +$2.66M |
| D | 2023-05-09 | 2023-05-09 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $88.94 | -75.6K | 28.5K | -73% | -$6.72M |
| M | 2023-05-04 | 2023-05-03+ | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $87.96 | -671 | 27.4K | -2% | -$59.0K |
| 2022-07-07 | 2022-07-07 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +2,032 | 35.4K | +6% | $0 | |
| 2022-06-01 | 2022-05-31 | OM | Outset Medical, Inc. | Szyman Catherine M. | Dir | A - Grant | $0.00 | +6,880 | 16.9K | +69% | $0 | |
| 2022-05-17 | 2022-05-17 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $95.93 | -1,730 | 33.3K | -5% | -$166.0K | |
| D | 2022-05-10 | 2022-05-08 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $0.00 | +12.2K | 42.5K | +40% | $0 |
| DM | 2022-05-10 | 2022-05-07+ | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $100.52 | -8,023 | 35.0K | -19% | -$806.5K |
| DM | 2022-05-05 | 2022-05-04 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $104.87 | -23.4K | 30.9K | -43% | -$2.45M |
| D | 2022-05-05 | 2022-05-04 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | F - Tax | $105.93 | -493 | 54.3K | -0.9% | -$52.2K |
| D | 2022-05-05 | 2022-05-03 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +3,775 | 31.3K | +14% | $0 |
| D | 2022-05-05 | 2022-05-04 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +23.4K | 54.7K | +75% | +$509.2K |
| DM | 2022-04-11 | 2022-04-11 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $122.04 | -20.0K | 44.0K | -31% | -$2.44M |
| D | 2022-04-11 | 2022-04-11 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +20.0K | 47.6K | +73% | +$435.2K |
| DM | 2022-03-14 | 2022-03-14 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $104.65 | -20.0K | 27.4K | -42% | -$2.09M |
| D | 2022-03-14 | 2022-03-14 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +20.0K | 47.4K | +73% | +$435.2K |
| D | 2022-02-18 | 2022-02-18 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +20.0K | 47.4K | +73% | +$435.2K |
| DM | 2022-02-18 | 2022-02-18 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $106.32 | -20.0K | 40.5K | -33% | -$2.13M |
| D | 2022-01-14 | 2022-01-14 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +10.0K | 37.4K | +36% | +$217.6K |
| DM | 2022-01-14 | 2022-01-14 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $119.53 | -10.0K | 36.3K | -22% | -$1.20M |
| D | 2021-12-17 | 2021-12-17 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +10.0K | 37.4K | +36% | +$217.6K |
| D | 2021-12-17 | 2021-12-17 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $121.24 | -10.0K | 27.4K | -27% | -$1.21M |
| D | 2021-11-19 | 2021-11-18 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +10.0K | 37.4K | +36% | +$217.6K |
| DM | 2021-11-19 | 2021-11-18 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $117.79 | -10.0K | 27.4K | -27% | -$1.18M |
| D | 2021-10-18 | 2021-10-18 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +9,741 | 37.2K | +36% | +$212.0K |
| DM | 2021-10-18 | 2021-10-18 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $110.41 | -9,741 | 34.6K | -22% | -$1.08M |
| D | 2021-09-08 | 2021-09-08 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +9,741 | 37.2K | +36% | +$212.0K |
| D | 2021-09-08 | 2021-09-08 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $121.28 | -9,741 | 27.4K | -26% | -$1.18M |
| 2021-08-05 | 2021-08-05 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | G - Gift | $0.00 | -344.39 | 27.4K | -1% | $0 | |
| D | 2021-08-02 | 2021-08-02 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $113.53 | -15.0K | 27.8K | -35% | -$1.70M |
| D | 2021-08-02 | 2021-08-02 | EW | Edwards Lifesciences | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +15.0K | 42.8K | +54% | +$326.4K |
Purchase Sale Sale after option exercise All abbreviations